Image analysis solutions provider iCAD Inc. will highlight several new features of their mammography CAD, MRI image analysis and colon CAD products.
Image analysis solutions provider iCAD Inc. will highlight several new features of their mammography CAD, MRI image analysis and colon CAD products.
In the company’s mammography line, the company will showcase its SecondLook Premier, a customizable mammography computer aided detection solution designed and developed using a 100 percent digital image database, the company said. The solution, which includes clinical decision support tools, is now available in Europe and company officials expect to receive FDA clearance for sale in the U.S. in 2012.
The company will also be demonstrating SecondLook Digital Multi-Vendor Solution, designed to work with the major digital mammography products as a practice expands.
iCAD will also be displaying its latest version of VersaVue enterprise software for MR image analysis, which has been optimized to improve speed and includes an upgraded user interface and automated templates for images and charts, said Peter Espo, vice president of global marketing.
iCAD will be featuring two partnerships in their MRI portfolio as works in progress - an MRI-guided prostate biopsy solution and a prostate MRI-TRUS fusion integration, Espo said.
Last month, the company entered in to a distribution agreement with Hitachi Medical Systems for iCAD’s SpectraLook with PrecisionPoint image analysis solution for breast MRI to be available with Hitachi’s Oasis and Echelon MRI systems.
Finally, iCAD will highlight its VeraLook CAD system for virtual colonoscopy, which was made available in 2010.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
New DEXA Scan Study Links Thyroid Medication Levothyroxine to Higher Bone Loss Risk in Seniors
November 25th 2024Use of the medication levothyroxine, commonly prescribed for hypothyroidism, was associated with greater long-term loss of total body bone mass in seniors, according to new DEXA research to be presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Is Contrast-Enhanced Mammography a Viable Option for Diagnosing Invasive Lobular Carcinoma?
December 15th 2023Contrast-enhanced mammography had a 98 percent sensitivity rate for diagnosing invasive lobular carcinoma and provided high conspicuity for 82 percent of detected lesions, according to research presented at the recent Radiological Society of North America (RSNA) conference.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.